Cannabinoids for Medical Purposes in Children: A Living Systematic Review
Abstract Aim: We developed a living systematic review (LSR) that will continuously map the safety and reported benefit data related to cannabinoid use for medical purposes in children. Methods: MEDLINE, Embase, PsycInfo, and the Cochrane Library were searched from inception to April 2023. Studies involving at least one child < 18 years who was administered plant‐derived or pharmaceutical cannabinoids as an intervention or treatment for medical conditions were included. Results: Of 37 189 identified citations, 276 studies were included: 84
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in